Probiotics and wellbeing in adults with type 1 diabetes

Not Applicable

Completed

• Conditions: type 1 diabetes; depression; stress; anxiety; Mental Health - Depression; Mental Health - Anxiety; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12620000294954
• Lead Sponsor: The University of Auckland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-03-04
• Study Completion: 2021-11-25
• Last Update Posted: 10 April 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 74

Inclusion Criteria

1.Must have had a diagnosis of type 1 diabetes for at least a year
2.Participants must be at least 18 years of age
3.Currently living in Auckland
4.Ability to provide informed consent
5.Ability to understand, read, and write English

Exclusion Criteria

1.Antibiotic or probiotic treatment within 3 months before enrolment
2.Surgery in the previous 3 months
3.Gastrointestinal infection within 1 month before enrolment
4.Immunodeficiency or immunosuppressed
5.Diagnosed with type 1 diabetes with pancreatitis
6.Pregnancy or breastfeeding

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Depression scores are assessed by the brief Depression, Anxiety, and Stress Scale (DASS; Lovibond & Lovibond, 1995). [Baseline and post-intervention (12 weeks after baseline)];Anxiety scores are assessed by the brief Depression, Anxiety, and Stress Scale (DASS; Lovibond & Lovibond, 1995). [Baseline and post-intervention (12 weeks after baseline)];Stress scores are assessed by the brief Depression, Anxiety, and Stress Scale (DASS; Lovibond & Lovibond, 1995). [Baseline and post-intervention (12 weeks after baseline)]